Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


Cutting edge: viral infection breaks NK cell tolerance to "missing self".

Sun JC, Lanier LL.

J Immunol. 2008 Dec 1;181(11):7453-7.


Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

Vago L, Forno B, Sormani MP, Crocchiolo R, Zino E, Di Terlizzi S, Lupo Stanghellini MT, Mazzi B, Perna SK, Bondanza A, Middleton D, Palini A, Bernardi M, Bacchetta R, Peccatori J, Rossini S, Roncarolo MG, Bordignon C, Bonini C, Ciceri F, Fleischhauer K.

Blood. 2008 Oct 15;112(8):3488-99. doi: 10.1182/blood-2007-07-103325. Epub 2008 Jul 21.


An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.

Dulphy N, Haas P, Busson M, Belhadj S, Peffault de Latour R, Robin M, Carmagnat M, Loiseau P, Tamouza R, Scieux C, Rabian C, Di Santo JP, Charron D, Janin A, Socié G, Toubert A.

J Immunol. 2008 Aug 1;181(3):2227-37.


MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

Yawata M, Yawata N, Draghi M, Partheniou F, Little AM, Parham P.

Blood. 2008 Sep 15;112(6):2369-80. doi: 10.1182/blood-2008-03-143727. Epub 2008 Jun 26.


Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.

Stern M, Ruggeri L, Capanni M, Mancusi A, Velardi A.

Blood. 2008 Aug 1;112(3):708-10. doi: 10.1182/blood-2008-02-137521. Epub 2008 May 23.


The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.

Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FT, Witt CS.

Blood. 2008 Jul 15;112(2):435-43. doi: 10.1182/blood-2008-01-132902. Epub 2008 Apr 2.


Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC.

J Immunol. 2007 Nov 1;179(9):5977-89. Erratum in: J Immunol. 2007 Dec 15;179(12):8570.


Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma.

Leung W, Handgretinger R, Iyengar R, Turner V, Holladay MS, Hale GA.

Br J Cancer. 2007 Aug 20;97(4):539-42. Epub 2007 Jul 31.


A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL, McQueen KL, Guethlein LA, Parham P, Miller JS.

Blood. 2007 Jul 15;110(2):578-86. Epub 2007 Mar 28.


Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, Stern M, Pende D, Perruccio K, Burchielli E, Topini F, Bianchi E, Aversa F, Martelli MF, Velardi A.

Blood. 2007 Jul 1;110(1):433-40. Epub 2007 Mar 19.


Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.

Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW, Schwan MA, Grosse-Wilde H, Wernet P, Uhrberg M.

J Immunol. 2007 Mar 15;178(6):3918-23.


Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ.

Blood. 2007 Jun 1;109(11):5058-61. Epub 2007 Feb 22.


Human natural killer cell development.

Freud AG, Caligiuri MA.

Immunol Rev. 2006 Dec;214:56-72. Review.


Human NK cell education by inhibitory receptors for MHC class I.

Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E.

Immunity. 2006 Aug;25(2):331-42. Epub 2006 Aug 10.


KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group.

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36.


Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO.

J Exp Med. 2005 Oct 3;202(7):1001-12.


KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, Miller JS.

Blood. 2005 Dec 15;106(13):4370-6. Epub 2005 Aug 30.


Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells.

Gays F, Martin K, Kenefeck R, Aust JG, Brooks CG.

J Immunol. 2005 Sep 1;175(5):2938-47. Erratum in: J Immunol. 2005 Dec 15;175(12):8441.


Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM.

Nature. 2005 Aug 4;436(7051):709-13.

Supplemental Content

Support Center